Kyverna Therapeutics, Inc. KYTX Finance Lease Liability, Current
Finance Lease Liability, Current at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s finance lease liability, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s finance lease liability, current?
- Kyverna Therapeutics, Inc. (KYTX) reported finance lease liability, current of $221K in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s finance lease liability, current changed year-over-year?
- Kyverna Therapeutics, Inc.'s finance lease liability, current decreased by 56.4% year-over-year, from $507K to $221K.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s finance lease liability, current?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s finance lease liability, current has grown at a -43.3% compound annual growth rate (CAGR), from $956K to $307K.
- What does finance lease liability, current mean?
- Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.